Digital measures to advance research & quality of life in schizophrenia

Schizophrenia spectrum disorders are complex and serious psychiatric disorders with multifaceted symptoms and associated difficulties, including psychosis, negative symptoms (e.g., loss of motivation), cognitive dysfunction, and functional impairment in major life areas.

This multifaceted clinical picture in schizophrenia is also heterogeneous, both across individuals and within individuals over time, posing a challenge for studying groups of individuals together.

Accurate clinical assessment and monitoring of these symptoms and their impact in daily life is often challenging and burdensome yet is crucial for the success of a clinical trial.

Download our latest whitepaper to learn how digital biomarkers are used to objectively and practically measure quality of life indicators important to patients.